<code id='83C426562D'></code><style id='83C426562D'></style>
    • <acronym id='83C426562D'></acronym>
      <center id='83C426562D'><center id='83C426562D'><tfoot id='83C426562D'></tfoot></center><abbr id='83C426562D'><dir id='83C426562D'><tfoot id='83C426562D'></tfoot><noframes id='83C426562D'>

    • <optgroup id='83C426562D'><strike id='83C426562D'><sup id='83C426562D'></sup></strike><code id='83C426562D'></code></optgroup>
        1. <b id='83C426562D'><label id='83C426562D'><select id='83C426562D'><dt id='83C426562D'><span id='83C426562D'></span></dt></select></label></b><u id='83C426562D'></u>
          <i id='83C426562D'><strike id='83C426562D'><tt id='83C426562D'><pre id='83C426562D'></pre></tt></strike></i>

          knowledge

          knowledge

          author:hotspot    Page View:3145
          Outgoing Bristol CEO Giovanni Caforio Emilie Pickering for STAT

          It’s changing of the guard time at pharmaceutical giant Bristol Myers Squibb. On Wednesday, CEO Giovanni Caforio will step down. He’ll be replaced by Christopher Boerner, who is currently chief operating officer.

          When Caforio took over in May 2015, Bristol was known as a big pharmaceutical firm with the high-flying stock of a biotechnology company, largely due to its role as the company that brought cancer immunotherapy to market. But Bristol stumbled in 2016 when its immunotherapy Opdivo failed to help patients with non-small cell cancer more than chemotherapy. Opdivo remained a big seller, but its failure allowed Merck’s rival Keytruda to move into position to become the best-selling medicine in the world. In 2019, Caforio tried to flip the script, buying the biotech Celgene for $74 billion.

          advertisement

          STAT recently sat down with Caforio, 59, to look back on what went wrong and right with his tenure. He also reflected on what it meant to be a physician — and the son of a physician. “We were speaking about patient stories over lunch and dinner, when I was a kid, and I think that drove my passion for medicine,” he said.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Medicare details structure of new drug price negotiation program
          Medicare details structure of new drug price negotiation program

          MedicareonFridayreleasednewdetailsabouthowitsnewdrugpricenegotiationprogramwillwork,justtwomonthsbef

          read more
          Apple Watch's A
          Apple Watch's A

          AdobeTheAppleWatchhassecuredanewqualificationfromtheFoodandDrugAdministrationthatcouldmakethesmartwa

          read more
          Virginia high school admissions case could be legal follow
          Virginia high school admissions case could be legal follow

          3:24DemonstratorsprotestoutsideoftheSupremeCourtinWashington,Thursday,June29,2023,aftertheSupremeCou

          read more

          Congress must protect the remaining independent doctors

          AdobeMorethan100,000doctorshave leftprivate practice andbecomeemployeesofhospitalsandothercorporatee